期刊文献+

细胞穿膜肽的研究进展与前景展望 被引量:6

下载PDF
导出
摘要 细胞穿膜肽(CPPs)是具有细胞膜穿透能力的小分子多肽,能携带大分子生物活性物质进入哺乳动物细胞,既不影响转导物质的生物活性且不会损伤细胞,其具体穿膜机制尚在研究,但并不影响其在生命科学研究领域中的应用。在穿膜肽研究的基础上,人们发现了包括肿瘤归巢肽,线粒体穿透肽,可活化细胞穿膜肽,嵌合肽,抗微生物肽等具有高效穿膜活性多肽片段,其作用更加广泛,他们给药物载体研究带来了机遇。然而,由于CPPs作为药物载体的应用过于复杂和难于控制,存在靶细胞摄取效率低及体内吸收、分布、生物利用度和毒性等方面问题,给其进一步研究和应用带来挑战。
作者 周华华 董坚
出处 《西部医学》 2012年第7期1410-1411,1414,共3页 Medical Journal of West China
基金 国家自然科学基金资助项目(No:3086033)
  • 相关文献

参考文献21

  • 1任锦,钦传光,徐春兰,王秋雨,左晓佳.细胞穿膜肽作为药物载体的研究进展[J].药学学报,2010,45(1):17-25. 被引量:24
  • 2周洲,朱金水.细胞穿透肽在肿瘤治疗中的研究进展[J].现代肿瘤学,2010,18(12):2497-2500.
  • 3Cai SR, Xu G, Becker-Hapak M, et al. The kinetics and tissue distribution of protein transduction in mice[J]. Eur J Pharm Sei, 2006,27(4) :311-319.
  • 4Ruoslahti E. Specialization of tumor vasculature [J]. Nat Rev Cancer,2002,2(2) : 83-90.
  • 5Ba].uk P, Hashizume H. McDonald D M[J]. Curr Opin Genet Dev,2005,15(1) :102-111.
  • 6Sugahara K N,Teesalu T, Karmali P P, et al. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs[J]. Science, 2010, 328(5981) : 1031-1035.
  • 7Park J H, von Maltzahn G,Xu M J, et al. Cooperative nanomate- rial system to sensitize,target,and treat tumors[J]. PNAS,2010,107(3):981-986.
  • 8Horton KL,Stewart KM, Fonseca SB,et al. Mitochondria-pen- etrating peptides[J]. Chem Bioi,2008,15(4):375-382.
  • 9黄发军,张华文.细胞穿透肽设计及肿瘤靶向治疗[J].生命的化学,2011,31(2):194-197. 被引量:2
  • 10Jiang T,Olson ES,Nguyen QT,et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides[J]. PNAS, 2004,101(51):17867-17872.

二级参考文献195

  • 1王薇,唐宁,张春玲,刘兴君,胡菡,张志翔,梁伟.细胞膜穿透肽促进脂质体包载的siRNA细胞内转运、定位及其功能[J].药学学报,2006,41(2):142-148. 被引量:6
  • 2严世荣,王立林,邱方城.细胞穿膜肽的研究进展[J].生物技术通讯,2006,17(5):796-798. 被引量:6
  • 3曲恒燕,孙曼霁.蛋白转导域内在化机制的研究进展[J].生命科学,2007,19(2):220-223. 被引量:5
  • 4Frankel AD et al. Cellular uptake of the tat protein from human immunodeficiency virus. Cell, 1988, 55:1189-1193.
  • 5Aroui Set al. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231. Cancer Lett, 2009, 285:28-38.
  • 6Agarwal A et al. Targeting a metalloprotease-PARl signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer. Mol Cancer Ther, 2008, 7:2746-2757.
  • 7Li Net al. The amino-terminal peptide of Bax perturbs intracellular Ca2+ homeostasis to enhance apoptosis in prostate cancer cells. Am J Physiol Cell Physiol, 2009, 296:C267-C272.
  • 8Sasaki Yet al. Cell-penetrating peptide-conjugated XIAP- inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation. FEBSJ, 2008, 275:6011-6021.
  • 9Yang E et al. Blockade of PARI signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. Cancer Res, 2009, 69:6223-6231.
  • 10Watkins CL et al. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD. J Control Release, 2009, 140:237-244.

共引文献38

同被引文献60

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部